Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial.
Kogure Y, Iwasawa S, Saka H, Hamamoto Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Ebi N, Inoue A, Kurata T, Okamoto I, Yamaguchi M, Harada T, Seike M, Ando M, Saito AM, Kubota K, Takenoyama M, Seto T, Yamamoto N, Gemma A. Kogure Y, et al. Among authors: saito am. Lancet Healthy Longev. 2021 Dec;2(12):e791-e800. doi: 10.1016/S2666-7568(21)00255-5. Lancet Healthy Longev. 2021. PMID: 36098037 Free article. Clinical Trial.
A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
Saka H, Kitagawa C, Ichinose Y, Takenoyama M, Ibata H, Kato T, Takami K, Yamashita M, Maeda T, Takeo S, Ueda H, Okabayashi K, Nagashima S, Oka T, Kouso H, Fukuyama S, Yoshimoto K, Shimokawa M, Saito AM, Ito S. Saka H, et al. Among authors: saito am. Trials. 2017 Sep 15;18(1):429. doi: 10.1186/s13063-017-2103-4. Trials. 2017. PMID: 28915900 Free PMC article. Clinical Trial.
Replacement of warfarin with a novel oral anticoagulant in endoscopic mucosal resection: a multicentre, open-label, randomised controlled trial.
Yamada T, Kada A, Uraoka T, Kuwai T, Watanabe N, Sasaki Y, Mabe K, Takahashi Y, Kagaya T, Kimura T, Hamada H, Saito AM, Harada N. Yamada T, et al. Among authors: saito am. BMJ Open Gastroenterol. 2017 Sep 15;4(1):e000152. doi: 10.1136/bmjgast-2017-000152. eCollection 2017. BMJ Open Gastroenterol. 2017. PMID: 29018538 Free PMC article.
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol.
Sekimizu M, Iguchi A, Mori T, Koga Y, Kada A, Saito AM, Horibe K. Sekimizu M, et al. Among authors: saito am. BMC Cancer. 2018 Feb 1;18(1):122. doi: 10.1186/s12885-018-4042-1. BMC Cancer. 2018. PMID: 29390984 Free PMC article. Clinical Trial.
High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm Trial.
Takase K, Kada A, Iwasaki H, Yoshida I, Sawamura M, Yoshio N, Yoshida S, Iida H, Otsuka M, Takafuta T, Ogata Y, Suehiro Y, Hirabayashi Y, Hishita T, Yoshida C, Ito T, Hidaka M, Tsutsumi I, Saito AM, Nagai H. Takase K, et al. Among authors: saito am. Acta Med Okayama. 2018 Apr;72(2):197-201. doi: 10.18926/AMO/55863. Acta Med Okayama. 2018. PMID: 29674771 Free article. Clinical Trial.
A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial.
Sekimizu M, Osumi T, Fukano R, Koga Y, Kada A, Saito AM, Mori T. Sekimizu M, et al. Among authors: saito am. Acta Med Okayama. 2018 Aug;72(4):431-436. doi: 10.18926/AMO/56184. Acta Med Okayama. 2018. PMID: 30140094 Free article.
149 results